In the News Researchers, Health Experts Are Smothered Under FDA Restrictions On Marijuana
“It’s ridiculous,” Steven Greenhut, Western Region director for the R Street Institute, told The Daily Caller News Foundation. “Having it as a Schedule I drug makes it impossible to do the serious research needed to determine what the effects are so it can be a more effective medical tool.”
